High-grade neuroendocrine carcinoma.
作者： Giulio Rossi , Alessandra Bisagni , Alberto Cavazza
DOI: 10.1097/MCP.0000000000000061
关键词:
摘要: Purpose of reviewThis review presents an update on classification, diagnosis and potentially ‘drugable’ molecular alterations small cell carcinoma (SCC) large neuroendocrine (LCNEC) the lung.Recent findingsThe main controversies in classification lung t
elsevier.com
wkhealth.com参考文章(49)
Thomas Hensing, Apoorva Chawla, Rishi Batra, Ravi Salgia, A Personalized Treatment for Lung Cancer: Molecular Pathways, Targeted Therapies, and Genomic Characterization Advances in Experimental Medicine and Biology. ,vol. 799, pp. 85- 117 ,(2014) , 10.1007/978-1-4614-8778-4_5
Pap tests may detect other cancers Cancer Discovery. ,vol. 3, pp. 1- 2 ,(2013) , 10.1158/2159-8290.CD-NB2013-014
Bonnie S. Glisson, Cesar A. Moran, Large-cell neuroendocrine carcinoma: controversies in diagnosis and treatment. Journal of The National Comprehensive Cancer Network. ,vol. 9, pp. 1122- 1129 ,(2011) , 10.6004/JNCCN.2011.0093
Natasha Rekhtman, Neuroendocrine tumors of the lung: an update. Archives of Pathology & Laboratory Medicine. ,vol. 134, pp. 1628- 1638 ,(2010) , 10.1043/2009-0583-RAR.1
Koji Tsuta, Diane C. Liu, Neda Kalhor, Ignacio I. Wistuba, Cesar A. Moran, Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas American Journal of Clinical Pathology. ,vol. 136, pp. 252- 259 ,(2011) , 10.1309/AJCPDXFOPXGEF0RP
Makoto Miki, Douglas W. Ball, R. Ilona Linnoila, Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung. Lung Cancer. ,vol. 75, pp. 58- 65 ,(2012) , 10.1016/J.LUNGCAN.2011.05.019
Muhammad F Bari, Helen Brown, Andrew G Nicholson, Keith M Kerr, John R Gosney, William A Wallace, Irshad Soomro, Salli Muller, Danielle Peat, Jonathan D Moore, Lesley A Ward, Maxim B Freidin, Eric Lim, Manu Vatish, David R J Snead, BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas Histopathology. ,vol. 64, pp. 547- 556 ,(2014) , 10.1111/HIS.12278
Giulio Rossi, Giuseppe Pelosi, Mattia Barbareschi, Paolo Graziano, Alberto Cavazza, Mauro Papotti, Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice. International Journal of Surgical Pathology. ,vol. 21, pp. 326- 336 ,(2013) , 10.1177/1066896913489346
Gabriel Sica, Madeline F. Vazquez, Nassar Altorki, Jeffrey Port, Paul C. Lee, Yifang Liu, Elizabeth Hyjek, Anjali Saqi, PAX-5 expression in pulmonary neuroendocrine neoplasms: its usefulness in surgical and fine-needle aspiration biopsy specimens. American Journal of Clinical Pathology. ,vol. 129, pp. 556- 562 ,(2008) , 10.1309/8J2PQHF603WHVL8K
Bertrand Grand, Aurélie Cazes, Pierre Mordant, Christophe Foucault, Antoine Dujon, Elizabeth Fabre Guillevin, Françoise Le Pimpec Barthes, Marc Riquet, High grade neuroendocrine lung tumors: Pathological characteristics, surgical management and prognostic implications Lung Cancer. ,vol. 81, pp. 404- 409 ,(2013) , 10.1016/J.LUNGCAN.2013.05.008